Product depth built for how pharma teams actually decide.
From molecule intelligence and risk scoring to NPV/eNPV, materials readiness, and audit-ready governance - every capability stays connected to the same asset record.
Five capabilities that generic tools cannot replicate.
Molecule Intelligence
A governed asset record from FDA-assisted import through enrichment, phase gates, and snapshots.
Risk Intelligence
PTRS, Business, IP, API/Supply, and KSM scoring separated from delivery risk and issues.
NPV / eNPV
Risk-adjusted value connected to probability, assumptions, and actuals.
Audit-ready governance
Traceability created as work happens - actor identity, change history, checksum, export.
Pharma project execution
Milestone -> task -> subtask, dependencies, critical path, risks, and issues.
Build and manage every asset record from one governed source of truth.
Create molecules manually or use the Portfolio Builder to start from public FDA datasets - then enrich each asset with commercial assumptions, phase gates, patent fields, risks, financials, materials, documents, and snapshots.
Portfolio Builder
FDA-assisted drug search and Orange Book-style data workflows to start a molecule record.
- Raw source payload stored for imported records
- Manual enrichment after creation
- Public data gives a starting point; your teams validate and enrich
Molecule profile
A complete asset profile across pharma, patent, and lifecycle fields.
- Dosage form, route, strength, container, storage, brand
- Filing category, market, development model
- Patent/IP: DS, DP, and AoP expiry dates
- Phase timelines, baselines, snapshots, hold/resume lifecycle, task boards
- Phase
- Ph II · active
- PTRS
- 68%
- Patent (DS)
- 2031
- eNPV
- $412m
Leadership visibility without a briefing-pack dependency.
Live visibility into molecule status, project progress, phase movement, risks, issues, resources, and financial signals across the pipeline.
Portfolio Command Centre
Portfolio Trends
Programme-level PMO Governance Dashboard
Portfolio and project Gantt views
Access rules by user, role, and discovery mode
Named owner accountability
Milestone to activity, with critical path, risks, and issues in one plan.
Structured project plans move pharma teams from informal coordination to accountable execution: Project -> Milestone -> Task -> SubTask, with dependencies, critical path, an interactive Gantt, a project risk register, and an issue tracker.
Plan structure
- Milestones, tasks, subtasks, activities
- Dependencies: FS, SS, FF, SF with lag days
- Interactive Gantt and critical path indicators
- Template lock mechanics for governed plans
Risk, issues & sign-off
- Project risk register: probability, impact, owner, mitigation, residual risk
- Issue tracker: blockers, deviations, change requests, escalation
- Task approvals, pending queue, rejection reasons, sign-off
- Comments, @mentions, documents, activity feed, audit trail
Know where risk sits before it becomes a missed milestone or bad capital decision.
PortiVix separates molecule-level decision risk from project-level delivery risk and active issues - giving leadership and PMO teams a clearer view of what could go wrong and what already has.
PTRS
Probability of technical and regulatory success at phase gates.
Business Risk
Commercial viability, competition intensity, and strategic fit.
IP Risk
Freedom-to-operate, patent vulnerability, and patent cliff exposure.
API / Supply Risk
Supplier concentration, lead time, country risk, and regulatory supply exposure.
KSM Risk
Tenant-defined key success metrics with scoring and commentary.
Project Risk Register
Probability, impact, owner, mitigation, contingency, residual risk, review date, status.
Issue Tracker
Blockers, deviations, change requests, linked tasks, comments, and escalation.
Connect capital decisions to molecule risk and execution reality.
Each molecule can carry a financial model with NPV and expected NPV - so leaders and finance teams understand value, probability, assumptions, and actuals in the same context as phase gates and risk. Try it: adjust the inputs and watch eNPV move.
Illustrative model. In PortiVix, eNPV connects to real assumptions, actuals, PTRS, and risk on each molecule.
Model inputs
API price, COGS, annual demand, overhead, other costs, investment, discount rate, project duration, probability of success, and start year.
Outputs & actuals
- NPV and eNPV for risk-adjusted prioritisation
- Annual cashflow actuals for comparison against the model
- What-if recalculation on save
Pharma decision flow
Bring material readiness into the same view as molecule and project decisions.
For API, formulation, and development teams, material and vendor readiness can decide whether timelines are real.
DQ, SU, EB, and Commercial quantity planning
Material items: type, CAS number, UOM, contribution %
Vendor records: unit price, budget, lead time, country of origin, markets
Materials Dashboard for portfolio-level KPIs
Version history for traceability
Reports built around decisions, not around what happens to be available.
Strategic, monitoring, operational, and compliance reports with saved views, scheduled delivery, exports, and AI-assisted portfolio questions that respect user access permissions.
Strategic
Portfolio Command Centre, PMO Governance Dashboard, Portfolio Trends, My Dashboard
Monitoring / Control Tower
Risk Control Tower, Issue Control Tower, Milestone Governance, Resource Utilisation
Operational
Project Summary, Task Completion, Workstream Progress, Milestone Tracking, Project Burndown, Employee Utilisation
Data & Compliance
Risk Registry, Issue Registry, Portfolio Health, Audit & Compliance
AI Assistant
Ask portfolio questions such as at-risk molecules, top eNPV opportunities, and portfolio health summaries. AI access is scoped by RBAC and audited through tools-used tracking - it only uses the data available to the authenticated user.
Evidence that exists before you need it.
Approval, phase, change, and audit records stay connected to the work as it happens - supporting regulated electronic-record readiness, including 21 CFR Part 11 readiness workflows, subject to customer validation.
Audit trail flow
See these capabilities mapped to your workflows.
We do not start with a generic demo. We map your portfolio, molecule, project, approval, reporting, and governance workflows first - then show how PortiVix would work for your organisation.